A well demonstrated experience in conducting clinical trials and health projects
With more than 10 years of experience in clinical trials and health management settings, we offer professional, innovative and efficient services related to Phase I-IV clinical studies, and also operational health support on the entire continent, with a deeper footprint in West and Central Africa. As such, we stand as a partner of choice for action on the continent and around.
Likak Research in numbers
- Studies/Projects: 47
- Sites: 40
- Countries: 15
- Clinical Research Associates and experts: 22
Among others, Likak Research took part to the following trials
Therapeutic area
Malaria
Phase
II & III
Population type
Adults
Sample size
1200
Country
Ghana
Mali
Nigeria
Therapeutic area
Rotavirus
Phase
III
Population type
Infants
Sample size
400
Country
Ghana
Therapeutic area
Tuberculosis
Phase
III
Population type
Infants
Sample size
800
Country
Kenya
Therapeutic area
Meningitis A
Phase
IIa, IIb & III
Population type
Infants, Adults
Sample size
300, 600, 1200
Country
Gambia
Ghana
Mali
Senegal
Therapeutic area
Rotavirus
Phase
II & III
Population type
Infants
Sample size
400
Country
Ghana
Therapeutic area
Malaria
Phase
III
Population type
Infants
Sample size
800
Country
Gabon
Therapeutic area
HIV
Phase
IIIb
Population type
Adults
Sample size
120
Country
Cameroon
Senegal
Therapeutic area
Phlebo thrombosis
Phase
Observational trial
Population type
Adults
Sample size
8000
Country
54 countries, 4 continents
Senegal
Therapeutic area
Ebola
Phase
Ib
Population type
Adults
Sample size
250
Country
Gabon
Therapeutic area
Diarrhea
Phase
Community trial
Population type
Children
Sample size
11500
Country
7 countries
Malawi
Mali
We conduct projects in more than 25 countries in Africa
- Burkina Faso
- Ivory Coast
- Cameroon
- Gabon
- Gambia
- Ghana
- Kenya
- Malawi
- Mali
- Mozambique
- Nigeria
- Senegal
- Tanzania